Sebastian Cuenca Miranda
Direktor/Vorstandsmitglied bei Spanish Issuers' Association
Aktive Positionen von Sebastian Cuenca Miranda
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Universidad CEU San Pablo | Corporate Officer/Principal | - | - |
Spanish Issuers' Association | Direktor/Vorstandsmitglied | 01.01.2006 | - |
Karriereverlauf von Sebastian Cuenca Miranda
Ehemalige bekannte Positionen von Sebastian Cuenca Miranda
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
PHARMA MAR, S.A. | General Counsel | - | 29.07.2019 |
Unternehmenssekretär | - | 29.07.2019 | |
Sylentis SA
Sylentis SA BiotechnologyHealth Technology Sylentis SA develops new ophthalmic drugs and novel therapies based on RNAi (gene silencig) technology. The company is headquartered in Madrid, Spain. | Unternehmenssekretär | - | - |
Xylazel SA
Xylazel SA Industrial SpecialtiesProcess Industries Xylazel SA manufactures paints, varnishes and allied products. It specializes in the manufacture of protective products for wood, metal, gardens, paintings and walls. The firm’s products include primers and treatments, outdoor lasurs, antioxidant enamels metal spray accessories, indoor and outdoor paint, universal sprays, powder putty and diluents. The company was founded in 1975 and is headquartered in Pontevedra, Spain. | Unternehmenssekretär | - | - |
ZELTIA SA | Unternehmenssekretär | 18.11.2010 | - |
Ausbildung von Sebastian Cuenca Miranda
Instituto Catolico de Administracion y Direccion de Empresas | Undergraduate Degree |
Statistik
International
Spanien | 8 |
Operativ
Corporate Secretary | 4 |
General Counsel | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Process Industries | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
PHARMA MAR, S.A. | Health Technology |
Private Unternehmen | 4 |
---|---|
Zeltia SA
Zeltia SA BiotechnologyHealth Technology Zeltia SA is a holding company, which develops marine-based drugs in the field of oncology. It operates through the Biopharmaceuticals and Consumer Chemicals segments. The Biopharmaceuticals segment engages in the research and marketing of anti-tumor drugs, diagnosis kits, and development of therapies based on reducing or silencing gene expression. The Consumer Chemicals segment produces and markets insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and related products. The company was founded on August 3, 1939 and is headquartered in Madrid, Spain. | Health Technology |
Xylazel SA
Xylazel SA Industrial SpecialtiesProcess Industries Xylazel SA manufactures paints, varnishes and allied products. It specializes in the manufacture of protective products for wood, metal, gardens, paintings and walls. The firm’s products include primers and treatments, outdoor lasurs, antioxidant enamels metal spray accessories, indoor and outdoor paint, universal sprays, powder putty and diluents. The company was founded in 1975 and is headquartered in Pontevedra, Spain. | Process Industries |
Sylentis SA
Sylentis SA BiotechnologyHealth Technology Sylentis SA develops new ophthalmic drugs and novel therapies based on RNAi (gene silencig) technology. The company is headquartered in Madrid, Spain. | Health Technology |
Spanish Issuers' Association |